Could this be possible, how does it work, and where would we get it?

An anti-aging drug brought by the company Loyal, could be available to veterinarians in the near future.

The company Loyal is in the works developing drugs to prolong the life of aging pets.

This week they announced they have pushed through the first of three steps to gain approval from the US Food and Drug Administration (FDA).

The drug called LOY-001 is an injection for dogs over 7 years of age, weighing over 40 pounds.
The treatment would be received every 3-6 mnths by a veterinarian.
The goal would be to “slow down big dog growth factors.”

CEO and founder tells The Business Insider, “What the longevity field is trying to do is target the way we age holistically.”
So what Loyal intends to do is hopefully extend the amount of time a dog can live.
Their studies showed this new drug “improved clinically-relevant aging parameters.” They have been targeting the large breed with shorter lifespans. Lifespans that sometimes range half the amount of time than that of a smaller breed, like the chihuahua.
According to Loyal “large breed dogs have highly elevated levels of IGF-1, a hormone that drives cell growth.” Their explanation of the new drug goes on to explain that high levels of IGF-1 in adult dogs are believed to accelerate their aging and reduce their healthy lifespan.”
LOY-001 is said to “extend lifespan in part by reducing IGF-1 to levels seen in smaller-breed dogs.”

Of course lifespans vary in species. From people to animals, size, genetics, among other factors.

But if this drug becomes available and effective, what a breakthrough it will be in understanding and slowing down the age process.